Reduction of 13-deoxydoxorubicin and daunorubicinol anthraquinones by human carbonyl reductase

Andrew Slupe, Berea Williams, Corianton Larson, Laura M. Lee, Toby Primbs, Amanda J. Bruesch, Chad Bjorklund, Don L. Warner, Jeffrey Peloquin, Susan E. Shadle, Hervé A. Gambliel, Barry J. Cusack, Richard D. Olson, Henry A. Charlier

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Carbonyl reductase (CR) catalyzes the nicotinamide adenine dinucleotide phosphate (NADPH)-dependent reduction of several carbonyls. Anthracyclines used to treat cancer are reduced by CR at the C13 carbonyl and the resulting metabolites are implicated in the cardiotoxicity associated with anthracycline therapy. CR also is believed to have a role in detoxifying quinones, raising the question whether CR catalyzes reduction of anthracycline quinones. Steady-state kinetic studies were done with several anthraquinone-containing compounds, including 13-deoxydoxorubicin and daunorubicinol, which lack the C13 carbonyl, thus unmasking the anthraquinone for study. kcat and k cat/Km values for 13-deoxydoxorubicin and daunorubicinol were nearly identical, indicating that that the efficiency of quinone reduction was unaffected by the differences at the C13 position. kcat and kcat/Km values were much smaller for the analogs than for the parent compounds, suggesting that the C13 carbonyl is preferred as a substrate over the quinone. CR also reduced structurally related quinone molecules with less favorable catalytic efficiency. Modeling studies with doxorubicin and carbonyl reductase revealed that methionine 234 sterically hinder the rings adjacent to the quinone, thus accounting for the lower catalytic efficiency. Reduction of the anthraquinones may further define the role of CR in anthracycline metabolism and may influence anthracycline cytotoxic and cardiotoxic mechanisms.

Original languageEnglish
Pages (from-to)365-376
Number of pages12
JournalCardiovascular Toxicology
Volume5
Issue number4
DOIs
StatePublished - 2005

Keywords

  • Anthracycline
  • Carbonyl reductase
  • Cardiotoxicity
  • Daunorubicin
  • Doxorubicin
  • Mitoxantrone
  • Naphthazarin

Fingerprint

Dive into the research topics of 'Reduction of 13-deoxydoxorubicin and daunorubicinol anthraquinones by human carbonyl reductase'. Together they form a unique fingerprint.

Cite this